Opportunity Information: Apply for CDC RFA GH15 1574SUPP16
Apply for CDC RFA GH15 1574SUPP16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "South African University-Based Technical Assistance aimed at Improving the Quality of HIV/AIDS and Related Services in SA under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Jan 09, 2016 and posted on Jan 09, 2016.
- Applicants must submit their applications by Mar 08, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The funding opportunity titled "South African University-Based Technical Assistance aimed at Improving the Quality of HIV/AIDS and Related Services in SA under PEPFAR" (Funding Opportunity Number: CDC RFA GH15-1574SUPP16) is a discretionary U.S. government grant administered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC) under CFDA 93.067. It uses a cooperative agreement mechanism, which generally means the CDC expects to have substantial involvement in the program during implementation rather than simply providing funds with minimal engagement. The posting and creation dates are January 9, 2016, with an application closing date of March 8, 2016. The announcement indicates an expectation of one award, while the award ceiling is listed as 0, which typically signals that the ceiling is not specified in the synopsis or is determined through other budget guidance rather than capped in the public summary.
Programmatically, the opportunity is designed to support implementation of the DREAMS initiative, a multi-partner effort launched in 2015 through a reported USD 210 million partnership between PEPFAR, the Bill and Melinda Gates Foundation, and the Nike Foundation. DREAMS stands for Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe, and its core purpose is to reduce new HIV infections among adolescent girls and young women (AGYW) in ten sub-Saharan African countries, including South Africa. The emphasis is on combining multiple evidence-based interventions and intentionally working beyond the health sector to address structural and social drivers that heighten HIV risk for girls and young women, such as poverty, gender inequality, sexual violence, and barriers to education. In other words, the approach is not limited to clinical HIV services; it blends health programming with education, protection, and community-level change strategies.
Geographically, DREAMS activities under this announcement are targeted to five priority districts in South Africa: eThekwini, uMgungundlovu, and uMkhanyakude in KwaZulu-Natal, and the City of Johannesburg and Ekurhuleni in Gauteng. Across these five districts there are 31 sub-districts, and DREAMS is intended to concentrate resources in 19 sub-districts identified as high burden and high transmission areas. This kind of targeting reflects a public health strategy of focusing intensive prevention and support packages where incidence and vulnerability are highest, with the goal of producing measurable reductions in new infections within a defined timeframe.
The DREAMS initiative objectives highlighted in the notice are organized into four broad categories: empowering girls and young women, mobilizing communities, strengthening families, and providing social protection. Taken together, these objectives signal a layered prevention model, where direct services to AGYW are reinforced by family and community environments that reduce violence, improve support, and expand access to schooling and protective resources. The announcement also ties DREAMS to concrete outcome targets for HIV incidence reduction among 15- to 24-year-old girls and young women: a 25 percent reduction by the end of 2016 and a 40 percent reduction by the end of 2017. Beyond HIV incidence, the initiative explicitly aims to improve broader life outcomes linked to HIV vulnerability, including increased secondary school enrollment, attendance, and completion, as well as reductions in violence and unintended pregnancy.
In terms of eligibility, the synopsis points to WITS Reproductive Health and HIV Institute in the eligible applicants section, and the broader eligibility field indicates "Others" with reference to additional information (not included in the excerpt). This suggests the opportunity may be narrowly targeted or otherwise structured so that a specific institution or type of organization, potentially university-based technical assistance capacity, is central to implementation. Overall, the grant is positioned as a PEPFAR-aligned investment to strengthen the quality and impact of HIV and related services for adolescent girls and young women in priority South African districts by delivering an integrated, evidence-driven DREAMS package that addresses both biomedical risk and the social conditions that shape vulnerability.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The opportunity is titled "South African University-Based Technical Assistance aimed at Improving the Quality of HIV/AIDS and Related Services in SA under PEPFAR."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA GH15-1574SUPP16.
Which U.S. agency is administering the grant?
The grant is administered by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC).
Is this a discretionary grant?
Yes. The notice describes it as a discretionary U.S. government grant.
What CFDA number applies to this opportunity?
The CFDA number listed is 93.067.
What funding mechanism is being used?
The opportunity uses a cooperative agreement mechanism.
What does a cooperative agreement imply about CDC involvement?
A cooperative agreement generally means CDC expects to have substantial involvement during program implementation, rather than only providing funding with minimal engagement.
When was the opportunity posted?
The posting date is January 9, 2016.
What is the application closing date?
The application closing date is March 8, 2016.
How many awards are expected?
The announcement indicates an expectation of one award.
Is there an award ceiling (maximum funding amount) stated?
The award ceiling is listed as 0, which typically indicates the ceiling is not specified in the public synopsis or may be determined through other budget guidance.
What initiative is this funding designed to support?
This opportunity is designed to support implementation of the DREAMS initiative.
What does DREAMS stand for?
DREAMS stands for Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe.
When was the DREAMS initiative launched?
The notice describes DREAMS as a multi-partner effort launched in 2015.
Who are the partners referenced in the DREAMS initiative?
The notice references a partnership between PEPFAR, the Bill and Melinda Gates Foundation, and the Nike Foundation.
What is the overall purpose of DREAMS?
The core purpose is to reduce new HIV infections among adolescent girls and young women (AGYW) in ten sub-Saharan African countries, including South Africa.
Who is the primary target population?
The primary target population is adolescent girls and young women (AGYW), with specific incidence reduction targets stated for girls and young women ages 15 to 24.
Is the approach limited to clinical HIV services?
No. The notice emphasizes combining multiple evidence-based interventions and working beyond the health sector to address structural and social drivers of HIV risk.
What kinds of structural or social drivers does the notice mention?
The notice cites poverty, gender inequality, sexual violence, and barriers to education as examples of drivers that heighten HIV risk for girls and young women.
Where in South Africa are DREAMS activities targeted under this announcement?
Activities are targeted to five priority districts: eThekwini, uMgungundlovu, and uMkhanyakude in KwaZulu-Natal, and the City of Johannesburg and Ekurhuleni in Gauteng.
How many sub-districts are covered across the five priority districts?
The notice states there are 31 sub-districts across these five districts.
How many sub-districts are intended to be the focus for concentrated resources?
DREAMS is intended to concentrate resources in 19 sub-districts identified as high burden and high transmission areas.
What is the strategic reason for focusing on selected sub-districts?
The notice describes this as a public health strategy to concentrate intensive prevention and support packages where incidence and vulnerability are highest, aiming for measurable reductions in new infections within a defined timeframe.
How are DREAMS objectives organized in the notice?
The notice groups DREAMS objectives into four broad categories: empowering girls and young women, mobilizing communities, strengthening families, and providing social protection.
What kind of prevention model does the notice describe?
It describes a layered prevention model where direct services to adolescent girls and young women are reinforced by family and community environments that reduce violence, improve support, and expand access to schooling and protective resources.
What HIV incidence reduction targets are stated?
The notice states targets for reducing HIV incidence among 15- to 24-year-old girls and young women: 25 percent reduction by the end of 2016 and 40 percent reduction by the end of 2017.
Are there objectives beyond HIV incidence reduction?
Yes. The notice also aims to improve broader life outcomes linked to HIV vulnerability, including increased secondary school enrollment, attendance, and completion, as well as reductions in violence and unintended pregnancy.
What does the opportunity suggest about the type of activities funded?
Based on the notice, the funding supports an integrated, evidence-driven DREAMS package that blends health programming with education, protection, and community-level change strategies to address both biomedical risk and social conditions shaping vulnerability.
Who is listed as an eligible applicant?
The synopsis points to WITS Reproductive Health and HIV Institute in the eligible applicants section.
Does the notice indicate broader eligibility beyond the named institution?
The broader eligibility field is described as "Others" with a reference to additional information that is not included in the excerpt. Based on the excerpt alone, the full eligibility scope is not fully specified.
Does the notice suggest the opportunity may be narrowly targeted?
Yes. Because a specific institution (WITS Reproductive Health and HIV Institute) is identified in the eligible applicants section, the excerpt suggests the opportunity may be narrowly targeted or structured around a specific university-based technical assistance capacity.
How is this opportunity connected to PEPFAR?
The title and description position the grant as a PEPFAR-aligned investment supporting DREAMS implementation and improving the quality and impact of HIV and related services for adolescent girls and young women in priority districts in South Africa.
Browse more opportunities from the same agency: HHS-CDC
Browse more opportunities from the same category: Health
Next opportunity: Support for Health System Strengthening of Leadership, Governance and Quality Improvement in the Ministry of Health (MOH) in the Kingdom of Swaziland under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Establishment of a Strategic Partnership to Strengthen the South African National AIDS Council (SANAC) under PEPFAR
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1574SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1574SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Support for Health System Strengthening of Leadership, Governance and Quality Improvement in the Ministry of Health (MOH) in the Kingdom of Swaziland under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1584CONT16 Funding Number: CDC RFA GH15 1584CONT16 Agency: HHS-CDC Category: Health Funding Amount: $685,000 |
| Comprehensive Facility-Based Technical Assistance in the Context of Health Systems Strengthening in South Africa under PEPFAR Apply for CDC RFA GH12 1257SUPP16 Funding Number: CDC RFA GH12 1257SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Secretary’s Minority AIDS Initiative Funding to Increase HIV Prevention and Care Service Delivery among Health Centers Serving High HIV Prevalence Jurisdictions Apply for CDC RFA PS14 141003CONT16 Funding Number: CDC RFA PS14 141003CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Sodium Reduction in Communities Apply for CDC RFA DP16 1607 Funding Number: CDC RFA DP16 1607 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $500,000 |
| Well Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) Program Apply for CDC RFA DP13 130204CONT16 Funding Number: CDC RFA DP13 130204CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Building Ryan White HIV/AIDS Program Recipient Capacity to Engage People Living with HIV in Health Care Access Apply for HRSA 16 081 Funding Number: HRSA 16 081 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Part C Capacity Development Program Apply for HRSA 16 088 Funding Number: HRSA 16 088 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| State Public Health Approaches to Improving Arthritis Outcomes Apply for CDC RFA DP12 121005CONT16 Funding Number: CDC RFA DP12 121005CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| International Research Ethics Education and Curriculum Development Award (R25) Apply for PAR 16 081 Funding Number: PAR 16 081 Agency: HHS-NIH11 Category: Health Funding Amount: $230,000 |
| Cohort Study to Assess Population Impact of Current and Evolving Chronic Viral Hepatitis Treatment Apply for RFA PS 16 002 Funding Number: RFA PS 16 002 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $500,000 |
| NIDCD National Human Ear Tissue Laboratory Resource for Hearing and Balance Research (U24) Apply for RFA DC 17 001 Funding Number: RFA DC 17 001 Agency: HHS-NIH11 Category: Health Funding Amount: $475,000 |
| 2016 Cooperative Agreements to Benefit Homeless Individuals (Short Title: CABHI) Apply for SM 16 007 Funding Number: SM 16 007 Agency: HHS-SAMHS Category: Health Funding Amount: $1,500,000 |
| State Public Health Actions to Prevent and Control Diabetes, Heart Disease, Obesity and Associated Risk Factors and Promote School Health Apply for CDC RFA DP13 130504CONT16 Funding Number: CDC RFA DP13 130504CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Program Part F Dental Reimbursement Program Apply for HRSA 16 089 Funding Number: HRSA 16 089 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Conducting Public Health Research in Kenya Apply for RFA GH 16 006 Funding Number: RFA GH 16 006 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| Rural Health Research Center Cooperative Agreement Apply for HRSA 16 054 Funding Number: HRSA 16 054 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| International Bioethics Research Training Program (D43) Apply for PAR 16 082 Funding Number: PAR 16 082 Agency: HHS-NIH11 Category: Health Funding Amount: $230,000 |
| Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24) Apply for RFA RM 16 001 Funding Number: RFA RM 16 001 Agency: HHS-NIH11 Category: Health Funding Amount: $12,600,000 |
| Characterizing the Functional Elements in the Encyclopedia of DNA Elements (ENCODE) Catalog (UM1) Apply for RFA HG 16 003 Funding Number: RFA HG 16 003 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Early Comprehensive Childhood Systems Impact (ECCS Impact) Apply for HRSA 16 047 Funding Number: HRSA 16 047 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1574SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.